Herrmann Ken: insider trades.
Herrmann Ken reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($197K), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Herrmann Ken
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Aktis Oncology, Inc. (AKTS) | Director | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-20 | Aktis Oncology, Inc. | S | 1,350 | $24.56 | 0 | Form 4 |
| 2026-07-20 | Aktis Oncology, Inc. | S | 3,506 | $24.56 | 1,350 | Form 4 |
| 2026-07-20 | Aktis Oncology, Inc. | M | 1,350 | $1.91 | 4,856 | Form 4 |
| 2026-07-20 | Aktis Oncology, Inc. | M | 3,506 | $0.08 | 3,506 | Form 4 |
| 2026-07-17 | Aktis Oncology, Inc. | M | 3,065 | $0.08 | 3,065 | Form 4 |
| 2026-07-17 | Aktis Oncology, Inc. | S | 3,065 | $25.21 | 0 | Form 4 |
Questions
What stock did Herrmann Ken buy or sell?
Herrmann Ken reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($197K), across 1 company.
Is Herrmann Ken the same person as other filers with this name?
This page covers SEC CIK 2049757 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/herrmann-ken-2049757.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.